Portfolio

Company Announcements

Director/PDMR Shareholding

Related Companies

By LSE RNS

RNS Number : 7325D
Hikma Pharmaceuticals Plc
28 April 2017
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Khalid Nabilsi

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Disposal of 19,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.

c)

Price(s) and volume(s)

Price(s): £19.36

Volume(s): 19,500

d)

Aggregated information

 

Volume: 19,500

Price: £19.36

Total: £377,520.00

e)

Date of the transaction

28 April 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBXGDSIBDBGRI

Top of Page